A team of scientists from Germany has recently conducted a study to investigate the effect of inhaled prostacyclin on the prognosis of acute respiratory distress syndrome (ARDS) induced by coronavirus ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Three original papers published this week in the Journal of the ...
Corticosteroids, known as synthetic hormones, when used for severe pneumonia (non-COVID) can reduce all-cause mortality, and ...
MedPage Today on MSN
Corticosteroids May Boost Short-Term Survival in Pneumonia, ARDS
Corticosteroids may cut short-term mortality in patients with severe pneumonia or acute respiratory distress syndrome (ARDS), ...
Dublin, July 14, 2020 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome (ARDS) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report ...
Patients hospitalized with COVID-19 who had a combination of high blood pressure, obesity, diabetes, or other conditions associated with metabolic syndrome were at much higher risk of acute ...
Researchers at the University of Maryland School of Medicine have begun testing an experimental stem cell therapy to see whether it will help COVID-19 patients who are on ventilators with moderate to ...
83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated with two infusions of Mesoblast’s allogeneic cell therapy ...
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of ...
Among children with ARDS on mechanical ventilation (MV), mechanical power can be measured and adjusted to minimize lung injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback